Closing Bell cover image

Closing Bell: What Could February Hold For Your Money? 2/2/26

Closing Bell

00:00

Biotech Opportunities: RevMed and Others

Michelle highlights Revolution Medicine, an oral immunology candidate, and a myostatin drug for SMA as top near-term opportunities.

Play episode from 35:44
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app